|
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma |
|
|
|
Title: |
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma |
Author: |
Imbimbo, Martina Vitali, Milena Fabbri, Alessandra Ottaviano, Margaret Pasello, Giulia Petrini, Iacopo Palmieri, Giovannella Berardi, Rossana Zucali, Paolo Ganzinelli, Monica Marabese, Mirko Broggini, Massimo Marino, Mirella Trama, Annalisa Rulli, Eliana Hollander, Lital Pruneri, Giancarlo Torri, Valter Garassino, Marina Chiara |
Appeared in: |
Clinical lung cancer |
Paging: |
Volume 19 (2018) nr. 5 pages e811-e814 |
Year: |
2018 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|